|
|
||||||||
CLINICAL COMMENTARY |
From the Pediatric, Adolescent and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institutes of Child Health and Human Development, Bethesda, Maryland; and the Departments of Obstetrics and Gynecology at Maimonides Medical Center and the State University of New York Health Science Center at Brooklyn, Brooklyn, New York.
Address reprint requests to: Howard Minkoff, MD, Maimonides Medical Center, 967 48th Street, Brooklyn, NY 11219, E-mail: hminkoff{at}maimonidesmed.org
Hepatitis C virus infection, which is far more prevalent than human immunodeficiency virus (HIV)-1, can lead to cirrhosis, hepatocellular carcinoma, hepatic failure, and death. Like HIV-1, hepatitis C is transmitted parenterally, sexually, and from mother to infant. The American Academy of Pediatrics and the Centers for Disease Control and Prevention (CDC) recently recommended that all children born to women who are infected with hepatitis C virus or have risk factors for infection be screened for hepatitis C. Most infected women are asymptomatic and unaware of their infection, so routine prenatal testing is needed to fully meet that goal. We do not believe that current data justify universal testing, but we believe it is time for all obstetricians to test selectively based on risk factors.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |